跳轉至內容
Merck
全部照片(1)

重要文件

SAB4200270

Sigma-Aldrich

Anti-PSMB9 antibody, Mouse monoclonal

clone LMP2-37, purified from hybridoma cell culture

同義詞:

Monoclonal Anti-LMP2, Monoclonal Anti-PSMB6i, Monoclonal Anti-RING12, Monoclonal Anti-beta1i, Monoclonal Anti-proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2)

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352203

生物源

mouse

共軛

unconjugated

抗體表格

purified from hybridoma cell culture

抗體產品種類

primary antibodies

無性繁殖

LMP2-37, monoclonal

形狀

buffered aqueous solution

分子量

antigen 17 kDa

物種活性

human, mouse, rat

濃度

~1.0 mg/mL

技術

immunocytochemistry: suitable
indirect ELISA: suitable
western blot: 1.0-2.0 μg/mL using extracts of rat spleen

同型

IgG2a

UniProt登錄號

運輸包裝

dry ice

儲存溫度

−20°C

目標翻譯後修改

unmodified

基因資訊

human ... PSMB9(5698)

一般說明

Monoclonal Anti-PSMB9 (mouse IgG2a isotype) is derived from the hybridoma LMP2-37 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with human PSMB9 recombinant protein. Proteasome 20S subunit beta 9 (PSMB9) is present in the major histocompatibility complex (MHC) class II region. γ-interferon triggers the synthesis of three proteasomal subunits-PSMB9 (β1i), PSMB10 (β2i) and PSMB8 (β5i), which is a part of immunoproteasome.

免疫原

human PSMB9, recombinant protein.

應用

Monoclonal Anti-PSMB9 antibody produced in mouse has been used in:
  • flow cytometry
  • enzyme linked immunosorbent assay (ELISA)
  • immunoblotting
  • immunocytochemistry

生化/生理作用

Proteasome 20S subunit beta 9 (PSMB9) is used during antigen presentation. Aberrant levels of PSMB9 is involved in autoimmune disorders such as primary Sjogren′s syndrome and uterine leiomyosarcomas. The proteasome is a multicatalytic proteinase complex, which is involved in the regulation of essential cellular processes such as transcription, cell cycle progression, differentiation, apoptosis and in the control of stress and immune responses.

外觀

0.01M 磷酸缓冲盐溶液,pH 7.4,含 15mM 叠氮化钠。

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到適合的產品?  

試用我們的產品選擇工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR/JAK1/STAT3 signaling
Zhang XD, et al.
Cancer Cell, 29(5), 639-652 (2016)
The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases
Wang J, et al.
Cellular & Molecular Immunology, 3(4), 255-261 (2006)
Pro-inflammatory cytokines alter the immunopeptidome landscape by modulation of HLA-B expression
Javitt A, et al.
Frontiers in immunology, 10, 141-141 (2019)
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
Kloetzel PM and Ossendorp F
Current Opinion in Immunology, 16(1), 76-81 (2004)
Aaron Javitt et al.
Frontiers in immunology, 10, 141-141 (2019-03-06)
Antigen presentation on HLA molecules is a major mechanism by which the immune system monitors self and non-self-recognition. Importantly, HLA-I presentation has gained much attention through its role in eliciting anti-tumor immunity. Several determinants controlling the peptides presented on HLA

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務